An introduction to the complex connection between cannabis and schizophrenia / Marc W. Manseau, Michael T. Compton -- The epidemiology of cannabis use in the United States / Wilson M. Compton, Beth Han -- Cannabinoids and the brain / David L. Atkinson, Jeff K. Abbott -- Psychotomimetic and cognitive effects of 9 -- tetrahydrocannabinol in laboratory settings / John D. Cahill, Swapnil, Jose Cortes-Briones, Rajiv Radhakrishnan, Mohamed Sherif, Deepak C. D'Souza -- Psychotomimetic and cognitive effects of cannabis use in the general population / Nadia Solowij -- The association between cannabis use and schizotypy / Angelo B. Cedeño -- Effects of cannabis use in those at ultra-high risk for psychosis / Brian O'Donoghue, Meredith McHugh, Barnaby Nelson, Patrick McGorry -- Cannabis-induced psychotic disorders / Luca Pauselli -- Synthetic cannabinoids and synthetic cannabinoid-induced psychotic disorders / Papanti Duccio, Schifano Fabrizio, Orsolini Laura -- Cannabis use as an independent risk factor for, or component cause of, schizophrenia and related psychotic disorders / Jodi M. Gilman, Sara M. Sobolewski, Anne Eden Evins -- Cannabis use as a determinant of earlier age at onset of schizophrenia and related psychotic disorders / Claire Ramsay Wan, Beth Broussard -- The prevalence and effects of cannabis use among individuals with schizophrenia and related psychotic disorders / Ana Fresán, Rebeca Robles-García, Carlos-Alfonso Tovilla-Zarate -- The treatment of cannabis use disorder among individuals with a psychotic disorders / Peter Bosanac, Ana Lusicic, David J. Castle -- Cannabidol as a potential novel therapeutic agent for psychotic disorders / Serena Deiana, Erica Zamberletti.